DoD Neurofibromatosis Investigator-Initiated Research Award

Post Date

April 28th 2011

Application Due Date

August 1st 2011

Funding Opportunity Number

W81XWH-11-NFRP-IIRA

CFDA Number(s)

12.420

Funding Instrument Type(s)

Cooperative Agreement
Grant

Funding Activity Categories

Science and Technology and other Research and Development

Number of Awards

2

Eligibility Categories

Unrestricted

Funding

• Estimated Total Funding:

  $2100000

• Award Range:

  $None - $None

Grant Description

The NFRP Investigator-Initiated Research Award mechanism was first offered in FY96. Since then, 341 Investigator-Initiated Research Award applications have been received, and 96 have been recommended for funding. The NFRP Investigator-Initiated Research Award supports basic and clinically oriented research that will: ╔к_ Provide insight into the development of NF and Schwannomatosis, ╔к_ Result in substantial improvements over today╔к_s approach to the diagnosis and treatment of NF and/or Schwannomatosis, and ╔к_ Have an impact on the quality of life of persons with those diseases. DOD FY11 NFRP Investigator-Initiated Research Award 4 Areas of Encouragement: The FY11 NFRP encourages research applications that specifically address the critical needs of the NF community in the following areas: ╔к_ Complications of NF with high mortality such as neoplasms and cerebrovascular abnormalities; ╔к_ Complications of NF with high morbidity such as skeletal maladies, learning deficits, hormone-associated effects, and pain; ╔к_ Refinement and standardization of imaging techniques, molecular and cellular markers, and quality of life metrics for use in future clinical trials; and ╔к_ Translational research such as the development or preclinical testing of therapeutic agents for the treatment of NF. Applications must include preliminary data that is relevant to NF and/or Schwannomatosis and the proposed project. Optional Qualified Collaborator: The FY11 NFRP strongly supports collaborative research between basic scientists and clinical researchers, and between academic scientists and biotechnology/pharmaceutical industry scientists. Collaborations that bring new perspectives from other disciplines, or bring new investigators into the NF field are also strongly encouraged.

Contact Information

• Agency

  Department of Defense

• Office:

  Dept. of the Army -- USAMRAA

• Agency Contact:

  PA HELP: 301-682-5507; help@cdmrp.org
  eReceipt HELP: 301-682-5507; help@cdmrp.org
  

• Agency Mailing Address:

  CDMRP Help Desk

• Agency Email Address:

  help@cdmrp.org